Natural Capsules Limited conducted its 32nd Annual General Meeting, where shareholders discussed and approved various key resolutions. These included adopting the financial statements for the fiscal year ended March 31, 2025. Shareholders also re-appointed directors, approved the continuation of an Independent Director beyond 75 years, and re-appointed the Whole-time Director with revised remuneration. Additionally, resolutions covered related party transactions with its subsidiary, Natural Biogenex Private Limited, the appointment of Secretarial Auditors, and commission for Non-Executive Directors. Voting results will be disclosed separately.